Screener
Tenaya Therapeutics, Inc. TNYA Q2 2026 earnings
Reported August 5, 2026 · After market close
Revenue$1.1MMiss by $8.9M
EPS-$0.20Miss by $0.13
Revenue estimate$10.0M
EPS estimate-$0.07
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$800.0K
EPS estimate-$0.10
Versus estimates
Revenue
Q2 2026$1.1MMiss by $8.9M
Q1 2026$225.0KMiss by $7.3MDiluted EPS
FAQ
- When did Tenaya Therapeutics, Inc. report Q2 2026 earnings?
- Tenaya Therapeutics, Inc. (TNYA) reported Q2 2026 earnings on August 5, 2026 after market close.
- What were Tenaya Therapeutics, Inc.'s Q2 2026 revenue and EPS?
- Tenaya Therapeutics, Inc. reported revenue of $1.1M and eps of $-0.20 for Q2 2026.
- Did Tenaya Therapeutics, Inc. beat estimates in Q2 2026?
- Revenue missed the consensus estimate of $10.0M by $8.9M. EPS missed the consensus estimate of $-0.07 by $0.13.
- How did Tenaya Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 42.9% from $-0.14.
- Where can I find Tenaya Therapeutics, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-335098) and the 10-Q periodic report (0001193125-26-335140) directly on SEC EDGAR. The filing index links above go to sec.gov.
